User login
A new certification program for the implantation of left ventricular assist devices was released for review by the Joint Commission on Accreditation of Healthcare Organizations.
The certification will be conducted within the Disease‐Specific Care Certification program. Organizations seeking certification will have to meet the standards, practice guidelines, and performance measurements of the specific‐care program, as well as left ventricular assist device (LVAD)‐specific requirements based on those used in the Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart Failure (REMATCH) trial, according to the Association for the Advancement of Medical Instrumentation (AAMI). The AAMI expects the requirements to be ready for Centers for Medicare and Medicaid Services review by April.
A new certification program for the implantation of left ventricular assist devices was released for review by the Joint Commission on Accreditation of Healthcare Organizations.
The certification will be conducted within the Disease‐Specific Care Certification program. Organizations seeking certification will have to meet the standards, practice guidelines, and performance measurements of the specific‐care program, as well as left ventricular assist device (LVAD)‐specific requirements based on those used in the Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart Failure (REMATCH) trial, according to the Association for the Advancement of Medical Instrumentation (AAMI). The AAMI expects the requirements to be ready for Centers for Medicare and Medicaid Services review by April.
A new certification program for the implantation of left ventricular assist devices was released for review by the Joint Commission on Accreditation of Healthcare Organizations.
The certification will be conducted within the Disease‐Specific Care Certification program. Organizations seeking certification will have to meet the standards, practice guidelines, and performance measurements of the specific‐care program, as well as left ventricular assist device (LVAD)‐specific requirements based on those used in the Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart Failure (REMATCH) trial, according to the Association for the Advancement of Medical Instrumentation (AAMI). The AAMI expects the requirements to be ready for Centers for Medicare and Medicaid Services review by April.